Canopy Growth (CGC) Revenue (2019 - 2025)
Canopy Growth (CGC) reported Revenue of $153.0 million for Q4 2025, up 185.88% on a YoY basis from $53.5 million in Q4 2024, and up 215.75% sequentially from $48.5 million in Q3 2025.
Canopy Growth (CGC) Revenue (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Revenue data on file, last reported at $153.0 million in Q4 2025.
- For the quarter ending Q4 2025, Revenue rose 185.88% year-over-year to $153.0 million; the trailing twelve-month figure through Dec 2025 stood at $307.0 million (up 51.9% YoY), and the FY2026 full-year result was $45.4 million, up 44.77% from the prior year.
- Revenue improved to $153.0 million in Q4 2025, from $48.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $153.0 million in Q4 2025 to a low of -$273.7 million in Q1 2022.
- A 5-year average of $58.6 million and a median of $57.7 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue jumped 822.58% in 2021 and slumped 333.35% in 2022, its largest moves.
- Tracing CGC's Revenue over 5 years: stood at $123.0 million in 2021, then plunged by 49.17% to $62.5 million in 2022, then decreased by 7.75% to $57.7 million in 2023, then retreated by 7.19% to $53.5 million in 2024, then soared by 185.88% to $153.0 million in 2025.
- Business Quant data shows CGC's Revenue at $153.0 million in Q4 2025, $48.5 million in Q3 2025, and $52.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 3.98 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 2.26 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 6.98 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 781.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 3.51 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 814.50 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 1.37 Bn |
| 10 | Canopy Growth | 266.42 Mn | 491,750.88 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 48.45 Mn |
| Jun 30, 2025 | 52.06 Mn |
| Dec 31, 2024 | 53.52 Mn |
| Sep 30, 2024 | 46.18 Mn |
| Jun 30, 2024 | 48.41 Mn |
| Mar 31, 2024 | 54.02 Mn |
| Dec 31, 2023 | 57.66 Mn |
| Sep 30, 2023 | 51.91 Mn |
| Jun 30, 2023 | 56.77 Mn |
| Mar 31, 2023 | 85.98 Mn |
| Dec 31, 2022 | 62.51 Mn |
| Sep 30, 2022 | 67.43 Mn |
| Jun 30, 2022 | 93.08 Mn |
| Mar 31, 2022 | -273.68 Mn |
| Dec 31, 2021 | 122.99 Mn |
| Sep 30, 2021 | 104.36 Mn |
| Jun 30, 2021 | 110.81 Mn |
| Mar 31, 2021 | 117.28 Mn |
| Dec 31, 2020 | 13.33 Mn |